FAST
55
2
CINF
50
-7
BIIB
43
-2
DVA
50
-4
GME
88
2
AKAM
37
-3
COP
44
-3
AA
56
2
NEM
48
-4
ES
32
-7
DD
37
-7
L
43
-3
AXP
75
-3
CMS
50
-12
CAG
37
-3
AIG
56
-6
GPC
51
-5
CA
7
-27
FOX
62
-4
DHR
41
-6
FAST
55
2
CINF
50
-7
BIIB
43
-2
DVA
50
-4
GME
88
2
AKAM
37
-3
COP
44
-3
AA
56
2
NEM
48
-4
ES
32
-7
DD
37
-7
L
43
-3
AXP
75
-3
CMS
50
-12
CAG
37
-3
AIG
56
-6
GPC
51
-5
CA
7
-27
FOX
62
-4
DHR
41
-6
Financhill
Back

ADMA Biologics Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
64

ADMA
ADMA Biologics

Last Price:
$19.19
Seasonality Move:
14.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Top investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADMA is experiencing slight buying pressure.

ADMA Biologics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 21.43 Sell
20-day SMA: 22.01 Sell
50-day SMA: 20.26 Sell
200-day SMA: 18.21 Buy
8-day EMA: 20.95 Sell
20-day EMA: 21.39 Sell
50-day EMA: 20.42 Sell
200-day EMA: 17.32 Buy

ADMA Biologics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.08 Buy
Relative Strength Index (14 RSI): 41.47 Sell
Chaikin Money Flow: 598352 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.93 - 23.33) Sell
Bollinger Bands (100): (16.23 - 20.87) Buy

ADMA Biologics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for ADMA Biologics Stock

Is ADMA Biologics Stock a Buy?

  • ADMA Biologics share price is 19.47 while ADMA 8-day simple moving average is 21.43, which is a Sell signal.
  • The stock price of ADMA is 19.47 while ADMA Biologics 20-day SMA is 22.01, which makes it a Sell.
  • ADMA Biologics 50-day simple moving average is 20.26 while ADMA share price is 19.47, making it a Sell technically.
  • ADMA stock price is 19.47 and ADMA Biologics 200-day simple moving average is 18.21, creating a Buy signal.

ADMA Technical Analysis vs Fundamental Analysis

Buy
64
ADMA Biologics (ADMA) is a Buy

Is ADMA Biologics a Buy or a Sell?

  • ADMA Biologics stock is rated a Buy
    The current ADMA Biologics [ADMA] share price is $19.47. The Score for ADMA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.

ADMA Biologics Stock Info

Market Cap:
4.6B
Price in USD:
19.47
Share Volume:
4.2M

ADMA Biologics 52-Week Range

52-Week High:
25.67
52-Week Low:
8.91
Buy
64
ADMA Biologics (ADMA) is a Buy

ADMA Biologics Share Price Forecast

  • What is the ADMA Biologics stock price today?
    The ADMA Biologics stock price is 19.47 USD today.
  • Will ADMA stock go up or go down?
    ADMA Biologics> share price is forecast to RISE/FALL based on technical indicators
  • Is ADMA Biologics overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, ADMA Biologics is not overvalued.

Is ADMA Biologics Stock a Buy?

  • ADMA Biologics share price is 19.47 while ADMA 8-day exponential moving average is 20.95, which is a Sell signal.
  • The stock price of ADMA is 19.47 while ADMA Biologics 20-day EMA is 21.39, which makes it a Sell.
  • ADMA Biologics 50-day exponential moving average is 20.42 while ADMA share price is 19.47, making it a Sell technically.
  • ADMA stock price is 19.47 and ADMA Biologics 200-day simple moving average is 17.32, creating a Buy signal.

Fundamental Analysis of ADMA Biologics

Is ADMA Biologics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.35 per share.

Technical Analysis of ADMA Biologics

Should I short ADMA Biologics stock?

* ADMA Biologics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.